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Summarv
Dur ing the last  decades,  development  and d issemenat ion of  new medical
interventions occured rapidly. Consequently, the demand for as well as the costs
associated wi th heal th care increased st rongly.  Since then,  par t icu lar  heal th care
decis ion makers have t r ied to contro l  those heal th care expendi tures.  In  order  to
make just i fy ing choices possib le a growing need for  broad evaluat ions of  heal th
care in tervent ions arose,  and Medical  Technology Assessment  (MTA) and
ef f ic iency studies have emerged as new research d isc ip l ines.  Whi le the scope of  the
f i rs t  type of  research is  somewhat  broader,  both types inc lude an economic
evah,rat ion,  in  which the costs and heal th consequences of  two or  more a l ternat ives
are assessed and compared.
In the first part of this thesis an introduction to economic evaluation was given;
the consequences of  per forming an economic evaluat ion a longside a c l in ica l  t r ia l
(Chapter  2)  and the basic  concepts of  economic evaluat ion (Chapter  3)  were
addressed.  As economic evaluat ion is  a lways about  both heal th consequences and
costs,  the consequence of  adding an economic evaluat ion to a c l in ica l  t r ia l  is  a lways
that  besides medical  outcomes,  costs have to be assessed.  However,  other
adjustments in  the design may a lso be necessary,  such as,  for  instance,  the addi t ion
of  qual i ty  of  l i fe  va luat ions (ut i l i t ies)  and the extension of  the t ime hor izon.
Col laborat ion between heal th economists and c l in ica l  researchers is ,  therefore,
advisable f rom the star t  o f  the study design.  In  th is  way,  one can work on an
integrated design,  which is  su i table to answer both c l in ica l  and economic research
quest ions.
In the second (centra l )  par t  of  th is  thesis  the methods and resul ts  of  the MTA of
the Dutch lung transplantation programme were described. This study, an example
of  a t r ia l  inc luding an economic evaluat ion,  was in i t ia ted by the Dutch Nat ional
Heal th Insurance Board,  to  prov ide th is  board wi th in format ion about  the c l in ica l
effectiveness, quality of l i fe, costs, cost-effectiveness, and the need for and supply
of  donor lungs.  For  reason of  compar ison,  the study was set  up according to the
protocols of  the assessments of  the Dutch l iver  and heart  t ransplantat ion
programmes.  Select ion cr i ter ia  for  lung t ransplant  rec ip ients in  the t ransplantat ion
programme were the presence of  i r revers ib le,  progressively  d isabl ing end-stage
pulmonary or  card iopulmonary d isease.  The fo l lowing d iagnoses were
dist inguished:  emphysema, cyst ic  f ibros is ,  pulmonary hypertension,  pulmonary
f ibros is ,  and bronchiectas is .
The main focus of  th is  thesis  was on the economic evaluat ion,  which was par t  of
the MTA of lung transplantation. In this economic evaluation, the costs and effects
(: health consequences with regard to survival and quality of l i fe) for patients
enrolled in the Dutch lung transplantation programme were compared to the costs
and ef fects in  the s i tuat ion wi thout  a programme. For  such a compar ison,  in  general ,
Summary
a randomised c l in ica l  t r ia l  is  considered as the most  opt imal  s tudy design.  However,
in  v iew of  the expected posi t ive ef fects of  lung t ransplantat ion on surv iva l ,  i t  was
considered uneth ical  to  per form a randomised c l in ica l  t r ia l .  Therefore,  a l l  su i table
pat ients were admit ted to the t ransplantat ion programnre.  Consequent ly ,  only  costs
and effects with the programme were observed and costs and effects in the situation
wi thout  the programme ( in which pat ients receive a usual  t reatment  for  thei r  lung
disease unt i l  death)  were est imated on the base of  pre- t ransplantat ion ev idence.
The resul ts  of  the MTA of  lung t ransplantat ion revealed that ,  on average,
pat ients l ive longer i f  they are t ransplanted than compared to i f  they cont inue to
receive a convent ional  t reatment .  The average surv iva l  af ter  t ransplantat ion was
est imated at  7.4 years.  I f  not  t ransplanted,  on average,  pat ients would only have
l ived for  3.0 years,  which means that  (on average) pat ients l ive 4.4 years longer i f
they get  a lung t ransplantat ion.
The assessment  of  the qual i ty  of  l i fe  before and af ter  lung t ransplantat ion
(Chapter  5)  showed that  lung t ransplantat ion leads to a substant ia l  improvement  in
the heal th-re lated qual i ty  of  I i fe .  Before t ransplantat ion,  pat ients repor t  major
restr ic t ions on the d imensions mobi l i ty  and energy,  when the Not t ingham Heal th
Prof i le  was used.  In addi t ion,  they exper ienced a low level  of  wel l -being and
depressive symptoms,  d i f f icu l t ies in  per forming act iv i t ies of  dai ly  l i fe  (e.g.
dressing,  washing,  and going up and down sta i rs) ,  and a low abi l i ty  to  take care of
themselves.  About  4 months af ter  t ransplantat ion,  mobi l i ty ,  energy,  s leep,  act iv i t ies
of  dai ly  l i fe  dependency level ,  and dyspnea were par t icu lar ly  posi t ive ly  af fected by
the lung t ransplantat ion.  These improvements were mainta ined in the fo l lowing l5
months.
In contrast  to  the posi t ive ef fects of  lung t ransplantat ion on surv iva l  and qual i ty
of  l i fe ,  considerable costs were induced by the lung t ransplantat ion programme. A
compar ison between the costs in  the s i tuat ion wi th and wi thout  a t ransplantat ion
programme (Chapter  4)  showed that  the addi t ional  costs induced by lung
transplantat ion are about  hal f  a  mi l l ion Dutch gui lders per  t ransplanted pat ient .  In
th is  amount ,  besides costs induced wi th in heal th care,  a lso costs induced by the
pat ients and thei r  fami l ies and product ion losses are inc luded.
To address the cost-ef fect iveness of  the Dutch lung t ransplantat ion programme,
the addi t ional  costs of  lung t ransplantat ion were re lated to the gains in  surv iva l  and
qual i ty  of  l i fe  (Chapter  6) .  Main outcome was that  i t  costs Df l .152.000 to le t  one
pat ient  l ive one year  longer by receiv ing a lung t ransplant .  I f  the surv iva l  was
adjusted for  the qual i ty  of  l i fe ,  the outcome was an amount  of  Df l .  120.000 per
Qual i ty  Adjusted L i fe Year.  From scenar io analyses (Chapter  7)  i t  became c lear
that ,  i f  no changes in the t ransplantat ion programme are made,  those rat ios wi l l
become even h igher  in  the future
The resul ts  of  lung t ransplantat ion were compared to the resul ts  of  the Dutch
heart  and l iver  t ransplantat ion programmes (Chapter  9) .  This  analys is  showed that
the cost-effectiveness of lung transplantation is unfavourable compared to those of
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the Dutch heart  and l iver  t ransplantat ion programmes.  There are two main reasons
for  th is  unfavourable cost-ef fect iveness.  F i rs t  of  a l l ,  the surv iva l  gain is  re lat ive ly
smal l  for  lung t ransplant  rec ip ients,  due to a re lat ive ly  low surv iva l  af ter
t ransplantat ion and a re lat ive ly  long surv iva l  of  lung t ransplant  pat ients on the
wai t ing l is t .  Surv iva l  af ter  t ransplantat ion is  re lat ive ly  low,  because of  ( i )  the h igh
r isk of  acute re ject ion,  ( i i )  the h igh r isk of  in fect ion and ( i i i )  the invar iably  h igh
r isk of  bronchio l i t is  obl i terans syndrome (BOS),  a chronic t ransplant  dysfunct ion.
Surv ival  on the wai t ing l is t  is  re lat ive ly  h igh.  because of  a large proport ion of
pat ients wi th emphysema (usual ly  wi th a long surv iva l  on the wai t ing l is t )  and the
di f f icu l ty  to  determine the opt imal  moment to p lace a pat ient  on the wai t ing l is t .
Moreover,  a b ias towards premature p lacement  of  pat ients on the wai t ing l is t  may
be caused by the shor tage of  donor lungs and the a l locat ion a lgor i thm ( f i rs t  in ,  f i rs t
out)  of  the t ransplant  organisat ion.  A second reason for  the unfavourable cost-
ef fect iveness of  lung t ransplantat ion is  the h igh fo l low-up costs of  lung t ransplant
rec ip ients compared to hear t  and l iver  t ransplant  rec ip ients.  High fo l low-up costs
are caused by the in fect ion and re ject ion problems of  the pat ients,  inc luding the
development  of  BOS by a large par t  of  the pat ients.  From addi t ional  analyses
(Chapter  10)  i t  was showed that  the pat ients who developed BOS dur ing fo l low-up
induced considerable extra costs comnared to the Dat ients who d id not  develoo
B O S .
Besides a compar ison wi th other  Dutch t ransplantat ion programmes,  the resul ts
of  the Dutch lung t ransplantat ion study were compared to the resul ts  of  an
Amer ican study about  the cost-ef fect iveness of  lung t ransplantat ion.  l 'h is  Amer ican
study showed much favourable outcomes wi th regard to costs and cost-ef fect iveness
than the Dutch study.  Nevertheless,  the methods used in th is  s tudy were h ighly
quest ionable;  several  re levant  costs were excluded (e.g.  the costs of  fo l low-up)  and
no compar ison wi th the s i tuat ion wi thout  a t ransplantat ion programme was made.
By an extrapolat ion i t  was shown, that  h igher  costs and cost-ef fect iveness rat ios are
more  l i ke l y  f o r  t he  Amer i can  s í t ua t i on .
Final ly ,  i t  was invest igated how the cost-ef fect iveness of  lung t ransplantat ion
may be improved in the future (Chapter  9) .  Therefore,  besides the compar ison wi th
the other  two Dutch t ransplantat ion programnes,  sensi t iv i ty  analyses were
performed.  Those anaiyses revealed that ,  to  improve the cost-ef fect iveness of  lung
transplantat ion substant ia l ly ,  an improvement  in  the surv iva l  af ter  t ransplantat ion or
a decrease in the fo l low-up costs is  necessary.  Other  possib i l i t ies,  such as for
instance a change in the pat ient  inc lus ion cr i ter ia  (e.g.  the exclus ion of  pat ients wi th
the smal lest  gain in  surv iva l  and/or  qual i ty  of  l i fe) ,  are examined in the ef f ic iency
study of  lung t ransplantat ion,  which is  s t i l l  in  progress.
In the meant ime,  the min is ter  of  Heal th Af fa i rs  decided,  that  because of  the
proven ef fect iveness of  lung t ransplantat ion,  th is  procedure has to be inc luded into
the Dutch benef i t  packase.
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